Mirus Videos

1. Take The Turbulence Out Of Your Transfections 8/19/2026

   Run-to-run AAV titer variability can jeopardize production. Controlling incubation timing, DNA input, and media conditions improves yield and batch consistency.

2. Enabling Large-Scale Lentivirus Manufacturing With A Reliable Stabilizer 8/12/2026

   Scaling lentiviral vector production often brings tight timing constraints and process risks. Watch this presentation to see how innovative transfection strategies can improve batch consistency and streamline scale-up.

3. Large-Scale Lentivirus Manufacturing With A Transfection Complex Stabilizer 7/6/2026

   De-risk large-scale lentivirus manufacturing by mastering transfection complex stability. Find out how to control particle aggregation, reduce fluid volumes to 2%, and minimize expensive GMP costs.

4. Steady & Stable From Lab To Launch: Seamless Scale-Up With The First And Only GMP Transfection Stabilizer 2/24/2026

   Learn how extended transfection stability windows and reduced complex volumes solve critical scale-up challenges in AAV and lentivirus manufacturing at 1000+ liter production scales.

5. Overcoming Regulatory Hurdles In AAV Production 12/16/2025

   Demonstrating residual reagent clearance is a critical regulatory requirement in AAV manufacturing. Explore how specialized assays and strategic partnerships streamline compliance.

6. Innovating Upstream AAV Manufacturing For The Next Wave Of Gene Therapies 11/6/2025

   High demand for AAV vectors requires overcoming current manufacturing challenges. Discover an optimized platform engineered to maximize AAV productivity, ensuring commercial readiness and faster speed to market.

7. Is Your Current AAV Process Holding You Back? 9/2/2025

   A novel stabilization method extends transfection complex viability from minutes to hours, providing critical flexibility and de-risking the process for more predictable and efficient workflows.

8. Scale AAV Production Utilizing The Only Transfection Complex Stabilizer 4/21/2025

   Achieve greater stability and consistency in large-scale AAV transfection. Learn about an additive that maintains complex integrity over hours, simplifying bioreactor workflows significantly.

9. Mirus Bio Bio-Expo Live February 2025: Upstream Bioprocessing 3/17/2025

   AAV vector manufacturing is a bottleneck in cell and gene therapy. Watch to learn about a new transfection platform that boosts AAV titers and percent-full capsids to help simplify production workflows.

10. A Novel Transfection System For Cell And Gene Therapy Applications 10/3/2024

    An innovative transfection system addresses common production challenges by offering higher AAV titers, improved percent-full AAV capsids, and a straightforward workflow for AAV production platforms.